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Introduction
Veno-arterial extracorporeal membrane oxygenation
(VA ECMO) has been introduced in the management of
critical conditions caused by severe cardiac failure. How-
ever, literary evidence for the use of VA ECMO in non-
surgical patients remains insufficient.
Objectives
To analyze a group of non-surgical patients with cardio-
genic shock and refractory cardiac arrest treated with
VA ECMO in cardiovascular center.
Methods
Between January 2006 and March 2015 one hundred and
thirty-eight patients were treated in our institution with
mini-invasive active circulatory support or VA ECMO for
circulatory failure. We analyzed data from a subgroup of
87 primarily non-surgical patients (mean age 61 (31-84)
years, 80% were males), treated by VA ECMO.
Results
The major indication for circulatory support therapy was
cardiogenic shock, followed by refractory cardiac arrest,
arrhythmic storm, and support of high-risk interventions.
Median duration of circulatory support was 3 days, maxi-
mum 62 days. The all-cause 30-day mortality in our group
was 34.5%; in the subgroup of patients with severe refrac-
tory cardiogenic shock the 30-day mortality was 49.4%.
In patients with refractory cardiac arrest, where ECMO was
introduced during continuous chest compressions, 4 indivi-
duals from 18 treated survived with good neurological
outcome. We found significant survival differences between
subgroup with urgent circulatory support introduction and
patients with semi-urgent support (30-day mortality 44.1%
vs. 5.3%, P < 0.001). We observed significantly higher
lactate levels prior to ECMO insertion in survivors in com-
parison with non-survivors (P < 0.05); other baseline char-
acteristics including age or left-ventricle ejection fraction
were comparable. We evaluated also the role of cerebral/
peripheral near-infrared spectroscopy (NIRS) oximetry in
the non-invasive monitoring of global circulatory status in
patients with mini-invasive circulatory support.
Conclusions
VA ECMO is a promising tool in the management of
severely compromised patients with rapidly progressing
cardiogenic shock or refractory cardiac arrest. Frequently
the circulatory support therapy in these high-risk patients
represents the last chance to survive.
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